JPRN-jRCT2080222232未知2 期
Dose-finding study of HP-3000 in patients with idiopathic restless legs syndrome.
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 79age old（—）
- 性别
- All
入选标准
- •Patients meeting all four diagnostic criteria for RLS of the International RLS Study Group.
排除标准
- •-Patients with a history of hypersensitivity to ropinirole.
- •-Patients with clinically significant renal impairment or hepatic dysfunction.
- •-Patients who have any cutaneous abnormality at the planned application site that could be aggravated by application of the investigational product.
研究者
相似试验
未知
2 期
Phase II clinical study in patients with Parkinson's disease.Parkinson's diseaseJPRN-jRCT2080221631Hisamitsu Pharmaceutical Co., Inc.
未知
3 期
ong-term study of HP-3000 in patients with Parkinson's diseaseParkinson's diseaseJPRN-jRCT2080222696Hisamitsu Pharmaceutical Co.,Inc.
未知
2 期
Phase 2/3 clinical study of HP-3150 in patients with cancer pain.Cancer painJPRN-jRCT2080222905Hisamitsu Pharmaceutical Co., Inc
未知
2 期
Phase II clinical study of HP-3150 in patients with low back pain.ow back painJPRN-jRCT2080222960Hisamitsu Pharmaceutical Co., Inc
未知
1 期
Phase I/II study of HP-3060 in patients with allergic rhinitis.Allergic rhinitisJPRN-jRCT2080222141Hisamitsu Pharmaceutical Co., Inc.